These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 1638545)
21. Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia. Lee CR; Cervi D; Truong AH; Li YJ; Sarkar A; Ben-David Y Anticancer Res; 2003; 23(3A):2159-66. PubMed ID: 12894591 [TBL] [Abstract][Full Text] [Related]
22. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Casey G; Lo-Hsueh M; Lopez ME; Vogelstein B; Stanbridge EJ Oncogene; 1991 Oct; 6(10):1791-7. PubMed ID: 1923504 [TBL] [Abstract][Full Text] [Related]
23. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line. Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731 [TBL] [Abstract][Full Text] [Related]
24. Curative effect of split low dosage total-body irradiation on murine AIDS induced by Friend virus: the results and the possible mechanism. Shen RN; Lu L; Kaiser HE; Broxmeyer HE In Vivo; 1996; 10(2):191-9. PubMed ID: 8744800 [TBL] [Abstract][Full Text] [Related]
25. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748 [TBL] [Abstract][Full Text] [Related]
26. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Isaacs WB; Carter BS; Ewing CM Cancer Res; 1991 Sep; 51(17):4716-20. PubMed ID: 1873816 [TBL] [Abstract][Full Text] [Related]
27. Erythroleukaemia induction by the Friend spleen focus-forming virus. Ruscetti SK Baillieres Clin Haematol; 1995 Mar; 8(1):225-47. PubMed ID: 7663048 [TBL] [Abstract][Full Text] [Related]
28. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735 [TBL] [Abstract][Full Text] [Related]
29. The differential effects of mutant p53 alleles on advanced murine lung cancer. Jackson EL; Olive KP; Tuveson DA; Bronson R; Crowley D; Brown M; Jacks T Cancer Res; 2005 Nov; 65(22):10280-8. PubMed ID: 16288016 [TBL] [Abstract][Full Text] [Related]
30. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate. Chen YM; Chen PL; Arnaiz N; Goodrich D; Lee WH Oncogene; 1991 Oct; 6(10):1799-805. PubMed ID: 1923505 [TBL] [Abstract][Full Text] [Related]
31. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238 [TBL] [Abstract][Full Text] [Related]
32. Requirement of the single base insertion at the 3' end of the env-related gene of Friend spleen focus-forming virus for pathogenic activity and its effect on localization of the glycoprotein product (gp55). Amanuma H; Watanabe N; Nishi M; Ikawa Y J Virol; 1989 Nov; 63(11):4824-33. PubMed ID: 2552155 [TBL] [Abstract][Full Text] [Related]
33. SPI-1 transforming properties depend upon specifically activated forms of the EPOR. Pereira R; Raingeaud J; Pironin M; Ghysdael J; Quang CT Oncogene; 2000 Oct; 19(44):5106-10. PubMed ID: 11042699 [TBL] [Abstract][Full Text] [Related]
34. Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion. Afrikanova I; Yeh E; Bartos D; Watowich SS; Longmore GD Oncogene; 2002 Feb; 21(8):1272-84. PubMed ID: 11850847 [TBL] [Abstract][Full Text] [Related]
38. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Hoatlin ME; Kozak SL; Lilly F; Chakraborti A; Kozak CA; Kabat D Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9985-9. PubMed ID: 2175917 [TBL] [Abstract][Full Text] [Related]
39. Mutations in the env gene of friend spleen focus-forming virus overcome Fv-2r-mediated resistance to Friend virus-induced erythroleukemia. Majumdar MK; Cho CL; Fox MT; Eckner KL; Kozak S; Kabat D; Geib RW J Virol; 1992 Jun; 66(6):3652-60. PubMed ID: 1583724 [TBL] [Abstract][Full Text] [Related]
40. A deletion in the Friend spleen focus-forming virus env gene is necessary for its product (gp55) to be leukemogenic. Watanabe N; Nishi M; Ikawa Y; Amanuma H J Virol; 1990 Jun; 64(6):2678-86. PubMed ID: 2159537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]